Novo Nordisk Freezes Hiring as Costs Rise Despite Wegovy FDA Approval
Cost-cutting move reflects margin squeeze and rising competition in the weight-loss drug market.
Spurt in Road Accidents Makes Advanced Critical Care Crucial to Save Victims in ‘Golden Hour’
Satellite technology enables emergency responders to pinpoint accident locations with extreme accuracy, even in remote areas.
Sword Health Raises $40M, Pushes IPO to 2028 as Growth Strategy Shifts
Although the company is cash-flow positive, it is postponing a public listing as it focuses on expanding its AI-driven care model and strengthening its position through private funding.
AstraZeneca Deepens China Ties With $5.3 Billion CSPC AI Research Deal
The agreement reflects AstraZeneca’s renewed investment push in China through AI-driven development of therapies for chronic illnesses.
Novo Nordisk Ousts CEO as U.S. Rivals Gain Ground, Drug Pipeline Disappoints
Denmark’s pharmaceutical giant navigates leadership shake-up after Wegovy sales falter and investor confidence wanes.
Eli Lilly’s Zepbound Outperforms Novo Nordisk’s Wegovy in Head-to-Head Weight-Loss Trial
Lilly’s Zepbound shows superior results in weight loss, offering a potential edge in the $150 billion obesity drug market.
Novo Nordisk Cuts Sales Forecast Amid U.S. Slowdown, Expects Wegovy Recovery After FDA Crackdown
The Danish drugmaker’s revised outlook eases investor concerns as a looming ban on copycat Wegovy treatments is expected to help regain U.S. market share.
U.S. Pledges $500 Million to Develop Universal Vaccines
The $500 million investment aims to accelerate the development of vaccines capable of combating multiple viral strains, bolstering global health security.
Roche to Invest $50 Billion in U.S., Add 12,000 Jobs as Trade Challenges Mount
Roche’s U.S. expansion builds on decades of engagement in the country, including its ownership of San Francisco-based Genentech, a leading developer of cancer and biotech therapies. The company currently employs over 25,000 people in the U.S., and its new initiatives further deepen that relationship.